Recent headlines about marijuana being “rescheduled” under the Controlled Substances Act have sparked a wave of confusion among employers and applicants alike. At AB Global, we’ve been fielding the same question repeatedly:
Is marijuana legal now?
The short answer is no. And for employers, especially those with regulated or safety-sensitive workforces, the compliance landscape has not meaningfully changed.
While the executive action directed the Department of Justice and the DEA to begin the formal rulemaking process to consider rescheduling marijuana, that process is exactly that—a process. It involves scientific review, public comment, and regulatory analysis, and it can take many months (or longer) to complete. Until it does, federal law remains exactly where it is today.
That distinction matters.
Despite what social media posts and breaking-news banners may imply, marijuana is still classified as a federally controlled substance. Employer drug-free workplace requirements remain fully enforceable. Testing for THC is still permitted, positive results are still valid under most employer policies, and existing federal statutes and agency rules have not been overridden or relaxed.
For DOT-regulated employers, the message is even more straightforward: nothing has changed.
The U.S. Department of Transportation continues to prohibit marijuana use for safety-sensitive positions. THC testing requirements remain in place, state marijuana laws do not apply, and medical marijuana cards do not excuse positive results. Until the DOT formally updates its regulations—which it has not—compliance obligations remain exactly the same.
Where things become more complicated is at the state level.
Across the country, marijuana laws remain a patchwork of medical allowances, recreational legalization, employment protections, and employer carve-outs. Employers must balance federal requirements, industry regulations, state laws, and the realities of safety-sensitive versus non-safety-sensitive roles. There is no universal approach, which is why policy clarity and defensibility are more important now than ever.
It’s also important to understand what hasn’t changed:
Employers may still conduct pre-employment, random, post-accident, and reasonable-suspicion testing. THC-positive results remain reportable. Drug-free workplace policies are enforceable. DOT programs and federal contractor requirements remain intact. Even if rescheduling is finalized in the future, it will not automatically dismantle or invalidate existing employer testing programs.
This moment isn’t a call to overhaul policies—it’s a call to prepare thoughtfully.
At AB Global, we recommend employers take this opportunity to review drug and alcohol policies for clarity, ensure HR and hiring teams are equipped to answer applicant questions accurately, avoid premature changes based on headlines, and continue testing in accordance with federal, state, and industry requirements. Working with a compliance partner to monitor regulatory developments can help organizations stay ahead of change without creating unnecessary risk.
From our Gold Standard perspective, rescheduling may signal a long-term shift—but it does not create immediate legality, nor does it remove employer authority to test or enforce workplace safety standards.
Until the law formally changes, marijuana is not federally legal. Employer compliance obligations remain in force. DOT testing requirements are unchanged.
And clarity, especially in moments like this, remains the Gold Standard.
If you have questions about how these developments may affect your drug testing program, hiring practices, or workplace policies, AB Global is here to help you navigate what’s next—confidently, accurately, and compliantly.
